Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Rabeprazole Sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

103 API Suppliers, 30 USDMF, 15 CEP/COS, 18 JDMF, 20 EU WC, 16 KDMF, 10 NDC API, 53 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

80 Drugs in Development

80 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

378 FDF Dossiers, 15 FDA Orange Book, 148 Europe, 10 Canada, 73 Australia, 11 South Africa, 121 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - 10MG, CAPSULE, DELAYED RELEASE;ORAL - 5MG, TABLET, DELAYED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 20MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Evonik, 2 Rochem International Inc, 19 SPI Pharma, 9 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 37 BASF, 1 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 3 Finar, 13 Gangwal Chemicals, 10 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

70 Coating Systems & Additives, 67 Fillers, Diluents & Binders, 43 Disintegrants & Superdisintegrants, 38 Controlled & Modified Release, 36 Granulation, 35 Direct Compression, 34 Solubilizers, 31 Thickeners and Stabilizers, 26 Lubricants & Glidants, 21 Taste Masking, 21 Topical, 21 Parenteral, 20 Chewable & Orodispersible Aids, 20 Film Formers & Plasticizers, 14 Emulsifying Agents, 11 Co-Processed Excipients, 9 Rheology Modifiers, 6 Surfactant & Foaming Agents, 6 API Stability Enhancers, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

13 News #PharmaBuzz

13 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 71 Regulatory FDF Prices, 13 Annual Reports

MARKET PLACE

53 APIs, 10 FDF Dossiers, 1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 2 JP, 23 Others

ANALYTICAL

1 BioAnalytical Methods, 2 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
29/11/2025	Metrochem API Private Limited	India	Metrochem API Pvt. Ltd.	221MF10282	Rabeprazole sodium	2009-12-22	2009-12-22	Flat No. 302, Bhanu Enclave, Sunder Nagar, Erragadda, Hyderabad-500038, Telangana, India
29/11/2025	Dr. Reddy\'s Laboratories	India	Dr. Reddy's Laboratories Ltd.	303MF10057	RABEPRAZOLE SODIUM	2021-04-02	2021-04-02	8-2-337, Road No. 3, Banjara Hills, Hyderabad 500 034, TELANGANA, INDIA

Rabeprazole Sodium

Rabeprazole Sodium

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

103 API Suppliers

30 USDMF

15 CEP/COS

18 JDMF

20 EU WC

16 KDMF

10 NDC API

53 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

80 Drugs in Development

INTERMEDIATES

23 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

378 FDF Dossiers

15 FDA Orange Book

148 Europe

10 Canada

73 Australia

11 South Africa

121 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED RELEASE;ORAL - 10MG

CAPSULE, DELAYED RELEASE;ORAL - 5MG

TABLET, DELAYED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - 20MG

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Evonik

2 Rochem International Inc

19 SPI Pharma

9 DKSH

5 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

4 Kirsch Pharma

1 ACG Worldwide

5 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

37 BASF

1 CD Formulation

1 Clariant

14 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

3 Finar

13 Gangwal Chemicals

10 Ideal Cures

3 Ingredion Pharma Solutions

23 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

TABLET, DELAYED RELEASE;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons